India's drug price regulator backs ban on combination drugs
The National Pharmaceutical Pricing Authority has asked pharma companies to review if their drug formulations have "irrational" fixed dose combinations.
from IBTimes.co.in : Science http://ift.tt/22EEekK
from IBTimes.co.in : Science http://ift.tt/22EEekK
Commentaires
Enregistrer un commentaire